Aspen Phamacare said on Thursday the Competition and Markets Authority of the UK had confirmed its decision to impose a fine of about £2.1m (R45m) on the group.
Aspen had said in August it had reached a settlement and admitted liability for entering into an agreement to acquire a potential competitor, which relates to the supply of fludrocortisone in the UK.
Under that agreement, the £2.1m fine is the maximum penalty that could be imposed.
Aspen said on Thursday this brought the matter to a close.
In morning trade, the group’s share was down 1.5% to R146.98, on track for its worst one-day performance in about two weeks. — BusinessLIVE
Aspen confirms R45m fine by UK competition authorities
Aspen Phamacare said on Thursday the Competition and Markets Authority of the UK had confirmed its decision to impose a fine of about £2.1m (R45m) on the group.
Aspen had said in August it had reached a settlement and admitted liability for entering into an agreement to acquire a potential competitor, which relates to the supply of fludrocortisone in the UK.
Under that agreement, the £2.1m fine is the maximum penalty that could be imposed.
Aspen said on Thursday this brought the matter to a close.
In morning trade, the group’s share was down 1.5% to R146.98, on track for its worst one-day performance in about two weeks. — BusinessLIVE
Would you like to comment on this article?
Register (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Latest Videos
Most Read
Business
Business
Business
Business
Business